Rate My Professor Madhav Bhatia

Bhatia's research specializes in the molecular pharmacology and pathology of inflammation in conditions including acute pancreatitis, polymicrobial sepsis, burns, and arthritis. Key areas include the roles of hydrogen sulfide and substance P as mediators of inflammation and therapeutic targets, chemokines in disease pathogenesis, pancreatic acinar cell apoptosis in acute pancreatitis, and novel biomarkers for diagnosis and prognosis of inflammatory and infectious diseases. With over 190 peer-reviewed publications and review articles, plus more than 130 abstracts, his work has garnered over 14,000 citations and an h-index of 60, including one article cited more than 1,000 times and 39 cited over 100 times. Prominent publications encompass 'Hydrogen sulfide and substance P in inflammation' (Antioxidants & Redox Signaling, 2010), 'H2S and inflammation - an overview' (Handbook of Experimental Pharmacology, 2015), 'Role of chemokines in the pathogenesis of acute lung injury' (American Journal of Respiratory Cell and Molecular Biology, 2012), and 'Hydrogen sulfide in inflammation: a novel mediator and therapeutic target' (Antioxidants & Redox Signaling, 2021). Bhatia has been ranked among the top 2% of scientists worldwide for biochemistry (2022) and immunology (2021), and appointed Editor-in-Chief of Current Issues in Molecular Biology in 2022. His contributions have profoundly influenced the field, identifying new therapeutic avenues for inflammatory disorders.